Bridgeway Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-132,500
| Closed | -$115K | – | 1459 |
|
|
2023
Q2 | $115K | Sell |
132,500
-75,000
| -36% | -$65.2K | ﹤0.01% | 1236 |
|
|
2023
Q1 | $145K | Buy |
207,500
+50,000
| +32% | +$34.9K | ﹤0.01% | 1166 |
|
|
2022
Q4 | $129K | Sell |
157,500
-25,000
| -14% | -$20.5K | ﹤0.01% | 1180 |
|
|
2022
Q3 | $190K | Buy |
182,500
+82,500
| +83% | +$85.9K | 0.01% | 1151 |
|
|
2022
Q2 | $164K | Hold |
100,000
| – | – | ﹤0.01% | 1133 |
|
|
2022
Q1 | $294K | Buy |
+100,000
| New | +$294K | 0.01% | 1087 |
|
|
2020
Q4 | – | Sell |
-105,600
| Closed | -$729K | – | 1381 |
|
|
2020
Q3 | $729K | Sell |
105,600
-56,500
| -35% | -$390K | 0.02% | 770 |
|
|
2020
Q2 | $1.06M | Buy |
162,100
+64,000
| +65% | +$420K | 0.02% | 627 |
|
|
2020
Q1 | $183K | Sell |
98,100
-3,900
| -4% | -$7.28K | ﹤0.01% | 1081 |
|
|
2019
Q4 | $192K | Buy |
102,000
+13,900
| +16% | +$26.2K | ﹤0.01% | 1201 |
|
|
2019
Q3 | $125K | Buy |
+88,100
| New | +$125K | ﹤0.01% | 1230 |
|
|
2019
Q2 | – | Sell |
-141,800
| Closed | -$676K | – | 1413 |
|
|
2019
Q1 | $676K | Buy |
141,800
+42,600
| +43% | +$203K | 0.01% | 906 |
|
|
2018
Q4 | $421K | Buy |
+99,200
| New | +$421K | 0.01% | 1049 |
|